Heron Therapeutics, Inc. (HRTX)
1.37
0.00 (0.00%)
USD |
NASDAQ |
Dec 11, 16:00
1.365
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics EPS Diluted (Quarterly): -0.1027 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.50M |
| Revenue (Quarterly) | 38.21M |
| Total Expenses (Quarterly) | 55.71M |
| Enterprise Value | 344.02M |
| Gross Profit Margin (Quarterly) | 68.82% |
| Profit Margin (Quarterly) | -45.78% |
| Earnings Yield | -5.91% |
| Operating Earnings Yield | 0.91% |
| Normalized Earnings Yield | -2.350 |